In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
Level V
Where this comes from
- Record sourced from PubMed, PMID 33316194.
- Also identified by DOI 10.7326/ACPJ202012150-071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hopewell JC, Offer A, Haynes R, et al. <b>Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.</b> Eur Heart J. 2020;41:3336-42. 32702748.
Medical subject headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Muscular Diseases